AT

Abhishek Trimbak Bhosle

Active Director Director DIN 08538707
DIN 08538707 First appointment Aug 2019 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Trimbak Bhosle

Data last updated:

Abhishek Trimbak Bhosle is a Director at Excellion Pharma Private Limited (since 2019). The company operates in Food And Beverages.

DIN 08538707
Primary Designation Director
Industry Food And Beverages
First Appointment 16 Aug 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Excellion Pharma Private Limited U24304MH2019PTC329387
Director16 Aug 20192019Active

Board colleagues of Abhishek Trimbak Bhosle

NameDINCompanyDesignation
Vikas Trimbakrao Bhosle08538708Excellion Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Excellion Pharma Private Limited
Premium access

Shareholding and investment profile for Abhishek Trimbak Bhosle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Trimbak Bhosle

Abhishek Trimbak Bhosle currently holds 1 directorship: Excellion Pharma Private Limited (Director, since 16 Aug 2019).

Abhishek Trimbak Bhosle was first appointed on 16 Aug 2019 as Director at Excellion Pharma Private Limited.

The current boards of Abhishek Trimbak Bhosle's companies include Vikas Trimbakrao Bhosle (Excellion Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available